Navigation Links
Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
Date:5/21/2012

CHAPEL HILL, N.C., May 21, 2012 /PRNewswire/ -- Savvy vice presidents and directors across all pharmaceutical commercial functions are searching now for best-in-class organizational structures, critical activities, proven processes, and investment benchmarks that ensure sustained growth across global markets.

"In today's increasingly competitive health care environment, global leaders and managers need to have analysis from across the worldwide marketplace," says Best Practices CEO, Chris Bogan. "Information from one country or region is not enough."

To support pharmaceutical leaders tasked with global oversight of structuring, resourcing, and strategic planning, Best Practices, LLC launches Global Management Navigator within the Wizards & Analytics Search (http://www3.best-in-class.com/rw16.htm).

"The Global Management Navigator puts benchmarking research, insights and analysis from a worldwide perspective into leaders' hands and supports evidence-based and informed decision-making," Bogan explains. The new Wizard searches the Best Practice Database for global benchmarks in a specified function, group, process or role.

For example, one often-searched health care area is "medical science liaisons," a highly knowledgeable group who provide critical medical information to the practicing community on behalf of the companies that manufacture new medicines and/or devices. To demonstrate the power of the new search Wizards in the Best Practice Database Global Management Navigator using the popular search term "medical science liaisons," simply:

How to Use the Global Management Navigator:

  • Visit the Global Management Navigator at http://www3.best-in-class.com/rw16.htm.   
  • In the fifth text box, insert the evolving role of "medical science liaisons" in quotations.
  • Click the "Search Now" button to the right of the text box.
  • Review the list of relevant documents in the Best Practice Database.
  • Click on the document titles of most interest, including the first hit "Medical Science Liaison Services Excellence: Managing Internal Activities and Providing Oversight." (http://www3.best-in-class.com/rr1155.htm)

Best Practice Database documents include benchmarks and insights gathered from quantitative and qualitative primary research with executives at pharmaceutical companies. Subscribers to the Best Practice Database have access to these primary research results to make informed decisions in their functional areas. Within the documents, charts, graphs, and process maps enable executives to assess resource levels, responsibility scope, and performance metrics of their function.

For more information on the Global Management Navigator or how to determine if your group is among the low performers or the best-in-class performers, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide.

Best Practices, LLC's clients include the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our reports, database, and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017 Wound care devices and products ... the wound. The industry mainly consists of establishments engaged ... treatment of wounds caused by mechanical, chemical, thermal, and ... such as diabetes, skin related diseases, immunological diseases, and ... was the largest region in the wound care ...
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets has ... report to their offering. ... The global gas chromatograph market to grow at ... The report, Global Gas Chromatograph Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:3/29/2017)... DIEGO , March 29, 2017 Avelas Biosciences, Inc., ... from diagnosis through treatment, today announced that Carmine N. Stengone ... the company at the Needham & Company 16 th Annual ... (8:20 a.m. PDT) at the Westin Grand Central Hotel in ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... The Professional Squash ... has enlisted New York City-based sports and entertainment marketing firm Leverage Agency as ... opportunities for the Professional Squash Association (PSA), which includes first-time ever title sponsorship, ...
(Date:3/29/2017)... ... ... Sublime Naturals and its founder, Kathy Heshelow, are big fans of Turmeric. ... for thousands of years. , "The West has caught on, and has discovered Turmeric, ... Use it For Your Wellness. Overcome Inflammation, Enemy of the Body. " The ...
(Date:3/29/2017)... ... March 29, 2017 , ... Based on research from ... employers face in trying to balance both short-term and long-term benefits demands. ... to the growing complexity, companies are finding that the short-term strategies used to ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... documenting and diagramming network and data center assets and audio-video devices has recently ... request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
Breaking Medicine News(10 mins):